GlobeNewswire Inc | Oct 23, 2020 08:00AM EDT

October 23, 2020

RALEIGH, N.C., Oct. 23, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its third quarter 2020 financial results before the open of the U.S. financial markets onThursday, November 5, 2020. The Company will host a conference call and webcast at 8:30 AM Eastern Timeto discuss the results and provide an update on business operations.

Conference Call Dial-In & Webcast Information:

Date: Thursday, November 5, 2020Time: 8:30 AM Eastern TimeDomestic: 877-407-0789International: 201-689-8562Conference ID: 13710272Webcast: http://public.viavid.com/index.php?id=141502

AboutBioDelivery Sciences International, Inc.BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

2020BioDelivery Sciences International, Inc. All rights reserved.

Contact:Bob YedidLifeSci Advisors646-597-6989Bob@LifeSciAdvisors.com